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1. Introduction 
Normal isolated adrenal cell [l-3] and isolated 
adrenocortical carcinoma [4] cell preparations, hav- 
ing negligible phosphodiesterase activities [5,6], are 
useful in the direct study of comparative hormonal 
control mechanisms. Using the above two isolated 
cell systems as models, it has been demonstrated [4, 
6-91: a) that the biochemical lesion(s) responsible 
for the lack of stimulation of steroidogenesis by 
ACTH* or CAMP in the tumor cell is in the conver- 
sion of cholesterol to (20 S)-20-hydroxycholesterol; 
b) that the pregnenolone and progesterone incorpora- 
tion into deoxycorticosterone and corticosterone is 
inhibited by ACTH in the tumor cells in contrast to 
the normal adrenal cells; c) that some, but not all of 
these actions of the hormone are found to be dupli- 
cated by CAMP. In the present investigation the effect 
of ACTH and its presumed mediator CAMP on deoxy- 
corticosterone incorporation into corticosterone is 
compared in normal adrenal and adrenocortical carci- 
noma cells. 
Although the stimulation of 1 l/3-hydroxylase activ- 
ity by CAMP in the adrenal homogenates and in the 
mitochondrial preparations of the rat have been re- 
* Trivial names and abbreviations: ACTH, adrenocorticotropic 
hormone; CAMP, adenosine cyclic 3’:5’-monophosphate; 
Bt+AMP, N6-2’-O-dibutyryl adenosine 3’:5’-monophos- 
phate; pregnenolone, 5-pregnen-3pol-2O-one; corticoste- 
rone, 1113, 21-dihydroxy-4-pregnen-3, 20dione; deoxycorti- 
costerone, 21-hydroxy-4-pregnen-3, 20dione. 
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ported by another laboratory [lO,ll], such stimula- 
tion in intact cells has not been found in this study. 
2. Materials and methods 
Isolated adrenal and adrenocortical carcinoma cell 
preparations were made as previously described [l-4]. 
The method of incubation with double labeled radio- 
active precursors was as previously described [7]: in- 
cubation was carried out in 3 Teflon flasks. Each flask 
contained 20 ml isolated adrenal tumor cell suspen- 
sion [4] prepared from 1.5 g adrenal tumor tissue or 
the same amount of cell suspension obtained from 32 
adrenals of the rat [ 1,2]. In addition, to the appropri- 
ate cell suspension, the first flask contained a mixture 
of 0.20 PCi of [4-14C] deoxycorticosterone (specific 
activity 20-30 pCi/lmmole) and 4.0 #Zi correspond- 
ing [l ,2-3H2] deoxycorticosterone (specific activity 
30-50 Ci/mmole) (3H/14C ratio, 20.00); the second 
flask contained 0.20 I.tCi of [ L4C] deoxycorticosterone 
and the third flask 4.0 PCi of [3H] deoxycorticoste-- 
rone + ACTH (200 pU/ml) or BtzcAMP (1 mM). The 
incubation was continued for 150 min and the reac- 
tion was stopped by the addition of 15 ml of distilled 
water and 75 ml of’methylene chloride into each 
flask. The contents of the second flask which con- 
tamed [J4C] deoxycorticosterone were mixed with 
the contents of the third flask which contained [3H] 
deoxycorticosterone + ACTH or BtzcAMP. To the 
reaction mixture of the two flasks 15 mg of corti- 
costerone was added and the products processed 
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identically. 
The experiments with the preloading of the cells 
with [3H] deoxycorticosterone were conducted as 
previously described [ 12J; 20 ml of suspended cells 
obtained from adrenals of 32 rats were preincubated 
for 30 min with 8.0 E.tCi of [3H] deoxycorticosterone 
+ 5 mg of non-radioactive deoxycorticosterone; the 
cell pellet obtained by centrifugation [ 1,2] was 
washed with 20 ml Krebs-Ringer-bicarbonate buff- 
er which contained albumin and glucose; the cells 
were resuspended in 40 ml of fresh Krebs-Ringer- 
bicarbonate buffer containing albumin and glucose. 
One incubation flask contained 20 ml of cell suspen- 
sion with ACTH or Bt,cAMP. The incubation was 
carried out for 150 min and the reaction mixtures 
processed as mentioned previously except to the 
reaction mixture of each flask both deoxycortico- 
sterone (15 mg) and corticosterone (15 mg) were 
added. 
Deoxycorticosterone and corticosterone were pu- 
rified by thin-layer chromatography [7,&I 21. The 
isolated deoxycorticosterone was acetylated [7,13], 
further purified by thin-layer chromatography [7,8, 
121 and crystallized from acetone*-hexane to con- 
stant specific activity. The purified corticosterone 
was crystallized from acetone-ligroin until the spe- 
cific activity and (3H/14C) ratio were constant. 
3. Results 
3.1. Effect of ACTH on the incorporation of deoxy- 
corticosterone into corticosterone in isolated 
adrenal and adrenocortical carcinoma cells 
Studies carried out in the normal adrenal and 
adrenocortical carcinoma cells where one group of 
cells was incubated with [ 1 ,2-3HZ] deoxycortico- 
sterone + ACTH and the other group with [4-14C] 
deoxycorticosterone alone followed by mixing the 
two incubation solutions after terminating the incuba- 
tion, showed (table l), 26% stimulation by the hor- 
mone in the isolated adrenal cell and 47% stimulation 
in the adrenocortical carcinoma cells. 
In order to determine if the above effect of ACTH 
represents timulation of the enzyme or of the trans- 
port mechanisms in the plasma membrane,.the iso- 
lated adrenal and adrenocortical carcinoma cells were 
preincubated with [ 1,2-?H2] deoxycorticosterone and 
Table 1 
Effect of ACTH on the incorporation of 13H] deoxycorti- 
costerone into corticosterone in normal isolated adrenal and 
adrenocortical carcinoma cells. 
Isolated cells Crystalli- [ 3H/14C] ratio of corti- 
from ration costerone from 
Flask 1 Flask 2 + Flask 3 
Normal adrenal 1st 20.00 24.12 
2nd 20.06 25.10 
3rd 20.59 26.49 
Adrenocortical 1st 19.97 27.96 
carcinoma 2nd 17.76 26.71 
3rd 16.40 25.20 
The [3H/14C] ratios of corticosterone obtained after the 
incubation of [4-“C, 1,2-3H2]deoxycorticosterone with iso- 
lated adrenal and adrenocoitical carcinoma cells. Incubation 
was carried out in 3 flasks containing 20 ml isolated adrenal 
or adrenocortical carcinoma cell preparation as mentioned in 
Materials and methods. Flask 1 contained a mixture of 
[1,2-gH,] deoxycorticosterone (4.0 &i) + [4-“C]deoxy- 
corticosterone (0.20 rCi) (3H/14C ratio 20.00); flask 2 con- 
tamed [ 1,2-“Ha] deoxycorticosterone (4.0 @i) + ACTH 
(200 ~U/ml) and flask 3 contained [4-“cjdeoxycorti- 1 
costerone (0.20 r.&i). The incubation was 2.5 hr and the re- 
action was stopped by the addition of 75 ml methylene chlo- 
ride to each flask. The contents of the second and third flask 
were mixed and corticosterone isolated as described in 
Materials and methods. 
the effect of ACTH observed on these cells. Table 2, 
shows that the preloading of the cells eliminated the 
stimulation by ACTH in both normal and tumor cells. 
This shows that the stimulatory effect of the hormone 
was at the transport level of the plasma membrane of 
the normal adrenal and the adrenal tumor cell. 
To eliminate the possibility that the non-stimu- 
latory effect of ACTH in the preloaded cells might be 
due to the insufficient availability of the substrate, 
deoxycorticosterone, the latter steroid was isolated, 
purified and crystallized as the 21.acetyl derivative. 
The results in table 2 show that there was still more 
than 80% of the unused substrate, deoxycortico- 
sterone, in the incubation system. 
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Table 2 
Effect of ACTH on the incorporation of [‘HI deoxycortico- 
sterone into corticosterone in preloaded normal isolated 
adrenal and adrenocortical carcinoma cells 
Isolated 
cells 
from 
Compound Crystal- [ 3H] dpm of compound 
lization from 
Control + ACTH 
Normal 
adrenal 
Adreno- 
cortical 
carcinoma 
Deoxycortico- 
sterone 
acetate Crude 
1st 
Cortico- 
sterone 1st 
2nd 
3rd 
Deoxycorti- 
sterone 
1st 
Cortico- 
sterone 1st 
2nd 
1 239 000 1 245 000 
1 230 000 1 240 000 
206 500 243 000 
202 000 222 000 
200 400 219 000 
1 962 000 1 905 000 
69 500 66 100 
68 400 60 300 
The total [ 3H] dpm of the products (and their derivatives) 
obtained after the incubation of [ 1,2-3Hz] deoxycortico- 
sterone with isolated adrenal and adrenocortical carcinoma 
cells. 20 ml of isolated adrenal cell preparation obtained 
from adrenals of 32 rats or the same amount of cell suspen- 
sion obtained from 1.5 g adrenal tumor was preincubated 
with 5 mg of non-radioactive deoxycorticosterone + [ 1,2- 
‘Ha] deoxycorticosterone (8.0 PCi) for 30 min. The cells 
were washed and resuspended in 40 ml of Krebs-Ringer- 
bicarbonate buffer containing albumin and glucose. 
20 ml aliquot of cell suspension was added into one flask 
and the second flask contained 20 ml aliquot of cell suspen- 
sion + ACTH (200 ).umits/ml). The incubation was for 2.5 hr 
and the reaction was stopped by the addition of 75 ml 
methylene chloride to each flask. Deoxycorticosterone and 
corticosterone were isolated as described in Materials and 
methods. 
3.2. Effect of Bt,cAMP on the incorporation of 
deoxycorticosterone into corticosterone in iso- 
lated adrenal and adrenocortical carcinoma cells 
Previous studies [ 1,7] have shown that Bt2cAMP 
is a much better stimulator of steroidogenesis than 
CAMP in the isolated adrenal cell. It was demonstrated, 
there, that the mode of action of both of these cyclic 
nucleotides is the same. In order that ACTH in its ef- 
fect upon the incorporation of deoxycorticosterone 
into corticosterone might be compared with its presum- 
Table 3 
Effect of BtacAMP on the incorporation of [3H] deoxyv. 
corticosterone into corticosterone in normal isolated adrenal 
and adrenocortical carcinoma cells 
Isolated cells Crystalliz- [3H/14C] ratio of cortico- 
from ation sterone in 
Flask 1 Flask 2 + Flask 3 
Normal adrenal 1st 20.04 25.47 
2nd 20.06 27.11 
3rd 20.35 28.49 
Adrenocortical 
carcinoma 1st 20.00 21.47 
2nd 19.91 22.72 
3rd 19.86 22.57 
The [3H/14Cj t ra ios of the products obtained after the incu- 
bation of [4- 4C,1,2-3Hz]deoxycorticosterone with isloated 
adrenal and adrenocortical carcinoma cells. Conditions of the 
experiment were similar to the experiment in table 1. 
ed mediator, CAMP, studies were conducted in the pres- 
ence of Bt,cAMP on the conversion of [ 1,2-3H2]deoxy- 
corticosterone to corticosterone. A shown in table 3, this 
nucleotide, like ACTH, stimulated (34%) the incorpora- 
tion of deoxycorticosterone into corticosterone into nor- 
mal adrenal cells. Further, analogous to the ACTH effect, 
the preloading of isolated adrenal cells with [ 1,2-3H] de- 
oxycorticosterone eliminated the stimulatory effect 
of deoxycorticosterone (table 4). This shows that the 
effect of Bt,cAMP was also at the transport level of 
the plasma membrane. A total of 80 to 85% unused 
deoxycorticosterone was isolated from the incubation 
mixture, thus showing that marked diminution of the 
total substrate cannot explain the observed results. 
The results in table 3 show that, in constrast to the 
stimulatory effect of ACTH and Bt2cAMP in the nor- 
mal adrenal cell and also in contrast to the stimula- 
tory effect of ACTH in the adrenal tumor cell, Bt2 
CAMP did not have any stimulatory effect upon the 
deoxycorticosterone incorporation into cortico- 
sterone by the tumor cells. 
Although the results reported are from single ex- 
periments, they have been confirmed in others. The 
absolute values have varied from experiment to exper- 
iment but the relationship of the individual results 
were consistent between experiments. 
199 
Volume 38, number 2 FEBS LETTERS January 1914 
Table 4 
Effect of Bt,cAMP on the incorporation of [ 3H] deoxycorti- 
costerone into corticosterone in preloaded normal isolated 
adrenal cells. 
[ 3H] dpm of compound 
Compound Crystalli- from 
zation 
Control + BtacAMP 
Deoxycortico- 
sterone acetate Crude 1 177 000 1 182 000 
1st 1 169 000 1 178 000 
Corticosterone 1st 187 800 178 800 
2nd 183 500 177 600 
3rd 182 300 184 000 
The total [ 3H] dpm of the products (and their derivatives) ob- 
tamed after the incubation of [ 1,2-3H,] deoxycorticosterone 
with isolated adrenal cells. Conditions of the experiment 
were similar to the experiment in table 2. 
4. Discussion 
There is strong evidence that the stimulation of 
steroidogenesis by ACTH in the normal adrenal cell 
is mediated by CAMP [ 14-171. That the stimulatory 
activity of this nucleotide is on the rate limiting step, 
cholesterol to pregnenolone, has been demonstrated 
[15,18,19] and supported by this laboratory [1,2,7]. 
The hypothesis [ 121 of Garren et al. [ 16,201, con- 
cerning the mode of action of ACTH in the adrenal 
cell has been modified [ 121 in the light of new evi- 
dence, some of which is presented herein, that modi- 
fication involves the inclusion especially in the adre- 
nal tumor, of aspects of hormonal action which are 
independent of mediation by CAMP. 
The present studies conducted with the isolated 
adrenal and adrenocortical carcinoma cell demon- 
strate a unique effect of ACTH, which consists in the 
stimulation of deoxycorticosterone incorporation 
into corticosterone. The evidence has been provided 
that this requires the interposition of the plasma mem- 
brane since preloading the cells eliminates hormonal 
stimulation. It is, therefore, most probable that this 
effect is dependent on the transport of deoxycortico 
sterone across the plasma membrane of the normal 
and malignant adrenal cell. In the normal adrenal cell, 
Bt2cAMP duplicates the stimulatory effect of ACTH; 
and like the latter agent, the stimulation by Bt2cAMP 
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of deoxycorticosterone incorporation into cortico- 
sterone is shown to be at the transport level of the 
plasma membrane. 
Of particular interest, however, are the results ob- 
tained with the adrenocortical carcinoma cell, where, 
although, ACTH stimulates the transport of deoxy- 
corticosterone into the cell, Bt,cAMP lacks any sti- 
mulatory activity. This suggests that the change of the 
normal adrenal cell to the adrenal tumor cell leads to 
considerable modification of biochemical control pro- 
cesses at the membrane level which in turn leads to 
modification of intracellular steroid concentrations 
and their resultant metabolism. Indirect evidence that 
there are differences in the rates of plasma or mito- 
chondrial metabolism of (20 S)-20-hydroxychole- 
sterol and pregnenolone between the adrenal tumor 
and normal adrenal has been provided earlier [8]. The 
present studies showing that ACTH stimulates the 
transport of deoxycorticosterone into the cell may be 
quite important in view of the recent finding that the 
biosynthetic step, deoxycorticosterone to cortico- 
sterone, is a relatively slow step in the normal adrenal 
cell [ 121. The implication is that if the hormone can 
stimulate the transport of deoxycorticosterone across 
the membrane it can also transport the precursor out 
of the cell. The hormone could, therefore, regulate 
the availability of the substrates for various enzymic 
reactions. Since this action of the hormone can be 
mimicked by BtzcAMP, it may be inference be sug- 
gested that the action of the hormone is being medi- 
ated by CAMP. Since the stimulatory effect of ACTH 
is not duplicated by BtzcAMP in the tumor, it is sug- 
gested that the membrane phenomena in the malig- 
nant cell may be dependent on other factors, and pos- 
sibly on other cyclic nucleotides. Evidence has been 
provided earlier that in the same tumor, ACTH inhi- 
bits pregnenolone incorporation into corticosterone 
and this is distinctly different from the effect of 
CAMP [7]. 
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